Nearly 70% of the Australian adult population are either sedentary, or have low levels of physical activity. There has been interest in addressing this problem by the 'mHealth', or mobile Health, arena, which is concerned with the confluence of mobile technology and health promotion. The newer generation of activity pedometers has the ability to automatically upload information, to enable aggregation and meta-data analysis of individual patient data. We conducted a ten-week pilot trial of the Fitbit Zip® pedometer using a validated tool in ten volunteers, finding it highly acceptable to both participants and investigators. Data synching was ranked as 'very easy' or 'easy' by all participants, and investigators could successfully monitor activity levels remotely. Median (interquartile range) daily step counts of participants over the ten-week trial ranged from 5471 (4591-7026) to 18779 (15031-21505) steps. Sedentary time over the study period ranged from 1.4% to 33.3% of study days. Percentage of days reaching the target activity level of >10,000 steps/day varied markedly between participants from 4.5% to 95.7%. This study demonstrates the feasibility and acceptability of a remotely monitored pedometer-guided physical activity intervention. This technology may be useful to encourage increased exercise as a form of 'prehabilitation' of adequately screened at-risk surgical or obstetric patients.
The 2011-12 Australian Health Survey found that nearly 70% of the Australian adult population (almost 12 million individuals) are classified as either sedentary or as having low levels of physical activity 1 . The World Health Organization (WHO) has ascribed a 20%-30% increased risk of premature death to a sedentary lifestyle, compared to active people 2 . WHO recommendations are that adults aged 18 to 64 years should do at least 150 minutes of moderate-intensity aerobic physical activity throughout the week, or at least 75 minutes of vigorous-intensity aerobic physical activity throughout the week 3 . In Australia in 2011-2012, 56% of Australian adults did less than the national recommendations of 30 minutes of moderate intensity physical activity per day 1 . Previous literature has used pedometer-determined physical activity in adults to identify such underactivity: an average step count of less than 5,000 steps/day being classified as sedentary, and 5,000 to 7,499 steps per day as low activity 1 .
Various interventions have been tried to address this issue. Pedometer-guided physical activity interventions have been used successfully in a number of settings, both workplace and patient-based [5] [6] [7] [8] . A recent systematic review of eight randomised controlled trials and 18 observational studies, encompassing 2,767 participants, found an increase in physical activity of 27% over baseline as measured by step count, with a significant reduction in body mass index and blood pressure 9 . The new generation of wireless capable pedometers offer unique opportunities to engage remotely with various outpatient populations who may not be able to attend a regular clinic setting. Tailored exercise programs along with participant biofeedback offered by such devices may result in improved health outcomes. However, before these programs could be used in intervention trials, their feasibility and acceptability to patients would have to be assessed. The aim of the current study was to assess the feasibility of remotely gathering such data and the acceptability of the pedometer to participants.
Materials and methods
We performed a single centre, prospective pilot trial, coordinated by the Anaesthesia, Perioperative and Pain Medicine Unit, Melbourne Medical School, and the Department of Anaesthesia and Pain Management, Royal Melbourne Hospital. Prior approval was granted by the Melbourne Health Human Research Ethics Committee (approval number 2015.080). Ten volunteer participants aged over 18 years were recruited after informed consent between July and August 2015 via advertising flyers distributed around the Royal Melbourne Hospital campus. Inclusion criterion was the requirement for a smartphone capable of allowing data synching with the pedometer. Exclusion criteria included inadequate English comprehension, or a joint or muscle disorder sufficient to impair walking to a target of 10,000 steps daily.
The pedometer (Fitbit Zip®, Fitbit Inc., San Francisco, CA, USA) was used to provide feedback to participants based on step counts. This pedometer also records various categories of 'active minutes' when the activity level of the participant is more strenuous than regular walking, grouping these into lightly, fairly, or very active depending on step cadence. Each individual device was registered with participants' own mobile phones via the Fitbit App on either iOS (Apple, Cupertino, CA, USA) or Android (Google, Mountain View, CA, USA) platforms, which allowed automated data synching from the pedometer and upload to the 'Fitbit Cloud', for study coordinators to view step counts in real time. Each participant was registered with the Fitbit Cloud via an allocated, de-identified, password-protected email address. Participants were instructed at the commencement of the trial to wear the pedometer throughout waking hours and aim for a target of 10,000 steps/day, but no further encouragement was given over the ten-week intervention period. Individual participant data was viewed by the study coordinators each week, and aggregated data downloaded at the conclusion of the trial.
At the end of the trial period participants anonymously completed a descriptive 22-item questionnaire, previously developed and validated by an Australian team to assess the quality of three broad dimensions of mHealth: system quality, interaction quality and information quality 10 . The primary endpoint was the feasibility of using the Fitbit Zip pedometer to measure physical activity in volunteers, determined by the percentage of participants who followed through to study completion, and the integrity and completeness of electronic pedometer data gathered. The performance of the pedometer and 'cloud' platform in easily distinguishing sedentary from more active time was also an important feasibility outcome. The secondary endpoint was the acceptability of using the Fitbit Zip pedometer for the trial period, as measured by assessment of pedometer burden, restriction in wearing the device, pedometer loss, and ease of data synching, measured via five-point Likert scale. Acceptability to investigators with respect to data completeness, accuracy, and ability to be viewed online was also measured using Likert scales.
Statistical analysis
Continuous data were tested for normality using the Shapiro-Wilk test. Normally distributed data was summarised using mean (standard deviation), skewed data was summarised using median (interquartile range, IQR), and categorical data was summarised using number (%).
Results
Ten participants were recruited, nine of whom completed the ten-week intervention period, with one participant losing the pedometer after 18 days. Days were censored if less than 1000 steps were logged, as the pedometer was unlikely to have been worn continuously over that day. The number of uncensored days for which data were uploaded and viewable for the nine participants who completed the trial was 68 (63-70)(median, IQR). Median daily step counts of participants ranged between 5471 and 18779 steps. Daily activity levels are presented in Figure 1 .
Validated questionnaires based on the 22-item instrument described above (see Appendix) were completed by all ten participants. Questions encompassing all domains were ranked as strongly agreed or mostly agreed by the majority of participants. Exceptions were the questions 'It protects my personal information': 10% strongly disagreed, 60% neither agreed nor disagreed; and 'It does not share information with others': 10% strongly disagreed, 10% somewhat disagreed, 40% neither neither agreed nor disagreed. Data synching was ranked as easy or very easy by the entire cohort. There was some misplacing of the pedometer with one participant losing it outright, 20% misplacing it between once per week and once per month, 40% misplacing it less than once per month, and 30% never misplacing it. There were few concerns about restriction to activity in wearing the pedometer with only one participant finding it mildly restrictive, and the majority of participants (70%) found it either mildly enjoyable or extremely enjoyable to wear. All respondents stated they would recommend the pedometer to others, and would participate in a similar trial again. All investigators either mostly or strongly agreed that data was accurate, complete, and that participant data could be viewed at the appropriate time each week.
Discussion
This pilot trial has demonstrated the feasibility and acceptability of remote monitoring of a group of pedometer wearers. Our trial has successfully simulated many elements of outpatient clinic care: multiple 'patients', a single physical site, and coordination by a small number of clinicians to provide feedback from wireless-capable pedometers. Feasibility outcomes were successfully met, including participant follow-through to study conclusion, and ability of the pedometer-cloud platform to accurately upload and allow reporting of step data and sedentary time. Acceptability outcomes including pedometer burden, wearability, loss, ease of data synching, and availability were also achieved.
Considerable barriers exist in the outpatient setting to engagement with traditional models of healthcare, including transport, cost, and inflexibility of appointment times. The confluence of these newer technologies, including exercise hardware such as pedometers, and the participant engagement and information dissemination afforded by internet access, has the potential to improve participant physical activity while limiting the amount of required contact time with health professionals. The large proportion of the Australian population with internet access, coupled with increasing smartphone ownership, means such interventions have the potential to reach many people. A recent trial assessing exercise in women utilised a Facebook app to help participants log activity, working in a team to achieve a daily step target 11 . Similarly, newer internet-based exercise programs have been successfully trialled in a variety of patient populations with minimal direct patient contact 12, 13 . A home-based pedometer-guided walking program over 90 days in 27 patients with chronic obstructive pulmonary disease, utilising telephone rather than clinic follow-up, demonstrated the feasibility and safety of such an approach 14 .
The mHealth literature, however, has to date been characterised by a paucity of tools with which to assess the quality of such services or interventions. A few earlier studies have examined the quality of mHealth interventions from the perspective of participant interaction, platform integrity and content quality 15, 16 . More recently, an Australian team developed and validated the comprehensive instrument used in this trial that seeks to assess the quality of three broad dimensions of mHealth: system quality, interaction quality and information quality 10 . The resulting 22-item survey, refined and tested in two subsequent trials of 104 and 280 patients, represents perhaps the best model in the current literature for assessing an mHealth intervention. The results from this survey of our ten participants gives us confidence that the Fitbit Zip pedometer represents a feasible device, with participants appropriately reassured by ease of use, information quality, and feedback provided. The concerns expressed by some participants about data privacy will need to be addressed in a subsequent trial, perhaps through greater engagement and transparency about the safeguards in place to protect individuals' information. We believe overall the results are encouraging enough to proceed to a trial in an interventional cohort.
Some important limitations to our trial exist. Recruitment of volunteers may not mirror the real-world motivation of patients to both wear the pedometer and comply with synching requirements with their smartphone. Acceptability and feasibility outcomes assessed here may thus be overstated when comparing this cohort against a patient group. When considering how to use the results of this study to inform an interventional patient trial, important differences exist. A volunteer cohort may be expected to engage more with the feedback provided from their daily step counts, thereby reducing their sedentary time more than a patient group might. A further limitation lies in potential differences between a volunteer cohort and a patient group expected to be older, less 'tech-savvy', and with lower rates of smartphone ownership. Recent data from the Australian Communications and Media Authority, however, suggests the current prevalence of smartphone ownership amongst older people would not preclude ongoing research in this domain, with 58% of 55-64-year-olds and 31% of >65-year-olds utilising mobile telephones as portable internet devices 17 . The pedometer we used records step counts, thus other activities with different exertion patterns (e.g. cycling, weightlifting) will not be recorded as accurately. This is a recognised limitation in all trials utilising accelerometerbased devices, and is somewhat mitigated by proper education of participants. This may remain as a potential barrier in target populations for prehabilitation who find walking difficult, such as prior to knee or hip arthroplasty, or who have other reasons restricting activity. Prior literature, however, has seen prehabilitation programs in these cohorts successfully incorporate both pedometer-based activities and walking (usually as a component of a multi-modal exercise program) [18] [19] [20] . We believe that these groups are not precluded as targets for further research in this area.
Our findings support the feasibility of using this technology in a prospective interventional trial. An important difference in an interventional trial will be to provide participants with feedback from the study coordinators on their activity levels. This approach has been trialled by other research teams, with some positive results 14 , and other negative trials 21 . Relevant factors proposed that determine whether such an approach is successful in increasing participants' activity levels are individual motivation levels, as well as interactivity of feedback provided, connectivity of the technology used, and individualisation of physical activity plans with the patient 21 . Careful selection of patient groups likely to benefit from prehabilitation will be important, as well as balancing the risks of involvement in such a trial. These will all be relevant issues in designing a future trial.
Conclusion
In conclusion we found the Fitbit Zip pedometer to be a feasible, acceptable device to remotely monitor the activity levels of a cohort of participants. This technology may have benefits for prehabilitation of preoperative and other patient groups and warrants further investigation.
Question
The Fitbit platform is always available I can access the system whenever I need I can receive service right away
The system is simple to use It is easy to get service from the system 
